Developing Methods and Guidance to Improve Hybrid Study Designs
- Funded by Patient-Centered Outcomes Research Institute
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$124,272Funder
Patient-Centered Outcomes Research InstitutePrincipal Investigator
PhD. Jennifer LundResearch Location
United States of AmericaLead Research Institution
University of North Carolina at Chapel HillResearch Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease surveillance & mapping
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This project's enhancement will use a modeling tool developed in the original study and expand its use to COVID-19-related clinical trials. The team will use aggregated data identified in published clinical trials on real-world patient populations. The review will be used as the foundation for applying the visualization tools to compare trial populations to various targets, including real-world critically ill patients and patients identified via publicly available surveillance data. The results from this study will help to improve the understanding of the representativeness and generalizability of randomized controlled trials that assess treatments for COVID-19 and identify shifts in types of patients impacted by the pandemic over time to inform future waves of infection.